Literature DB >> 7214364

Urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in dogs.

E Okajima, T Hiramatsu, K Hirao, M Ijuin, Y Hirao, K Babaya, S Ikuma, S Ohara, T Shiomi, T Hijioka, H Ohishi.   

Abstract

Clinicopathological, radiological, and histological studies were performed on urinary bladder neoplasia induced by N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) in five adult beagle dogs and in ten adult mongrel dogs. Tumors of the urinary bladder developed in dogs given various daily doses of BBN p.o. for different periods. The latent period of tumor induction was 4 years in dogs receiving a daily dose of 80 mg of BBN, 2 to 2.5 years in dogs receiving a daily dose of 160 mg of BBN, and 1.5 years in dogs receiving a daily dose of 240 mg of BBN. The total dose of BBN ingested by the dogs until the first tumors were observed by urological examinations was nearly the same in all groups, 100 to 140 g. These results suggest that there is a correlation between dose and induction time, but further dose-response studies are required. Histologically, tumors of the urinary bladder were transitional cell papillomas or transitional cell carcinomas resembling morphologically those found in human cases. It is possible to observe the process of development of urinary bladder tumors from initial lesions to invasive tumors using routine urological examinations. We believe that this experimental model is valuable for clinicopathological studies of urinary bladder tumors.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7214364

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Features of squamous and adenocarcinoma in the same cell in a xenografted human transitional cell carcinoma: evidence of a common histogenesis?

Authors:  P J Russell; E J Wills; J Philips; J Wass; M Jelbart; P Gregory; D Raghavan
Journal:  Urol Res       Date:  1988

2.  Dose-response study of urinary bladder carcinogenesis in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine.

Authors:  N Ito; T Shirai; S Fukushima; M Hirose
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

3.  Rat urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine and N-methyl-N-nitrosourea.

Authors:  S Ozono; K Babaya; K Sasaki; S Okamoto; H Momose; K Fujimoto; K Tsumatani; H Yamaguchi; Y Hirao; E Okajima
Journal:  Urol Res       Date:  1990

Review 4.  N-Methyl-N-nitrosourea as a mammary carcinogenic agent.

Authors:  Ana I Faustino-Rocha; Rita Ferreira; Paula A Oliveira; Adelina Gama; Mário Ginja
Journal:  Tumour Biol       Date:  2015-09-19

5.  Effects of single chemotherapeutic agents on development of urinary bladder tumor induced by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) in rats.

Authors:  K Babaya; S Takahashi; H Momose; H Matsuki; K Sasaki; S Samma; S Ozono; Y Hirao; E Okajima
Journal:  Urol Res       Date:  1987

6.  Strain differences in mice with invasive bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.

Authors:  M Ohtani; T Kakizoe; S Sato; T Sugimura; S Fukushima
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

7.  Scanning electron microscopy of changes in the urinary bladder in dogs treated with N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).

Authors:  Y Hirao; K Sasaki; S Sanma; S Ozono; K Babaya; E Okajima
Journal:  Urol Res       Date:  1987

8.  Gene Expression and DNA Methylation Status of Glutathione S-Transferase Mu1 and Mu5 in Urothelial Carcinoma.

Authors:  Shou-Chieh Wang; Chin-Chin Huang; Cheng-Huang Shen; Lei-Chen Lin; Pei-Wen Zhao; Shih-Ying Chen; Yu-Chiao Deng; Yi-Wen Liu
Journal:  PLoS One       Date:  2016-07-12       Impact factor: 3.240

Review 9.  Active surveillance for nonmuscle invasive bladder cancer.

Authors:  Makito Miyake; Kiyohide Fujimoto; Yoshihiko Hirao
Journal:  Investig Clin Urol       Date:  2016-05-27

Review 10.  Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancer.

Authors:  Dmitriy Smolensky; Kusum Rathore; Maria Cekanova
Journal:  Drug Des Devel Ther       Date:  2016-10-05       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.